Roster of the Clinical Chemistry and Clinical Toxicology Devices Panel
Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including clinical toxicology, clinical chemistry, endocrinology and oncology and makes appropriate recommendations to the Commissioner of Food and Drugs.
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 3
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Henry C. Nipper, Ph.D., DABCC
Expertise: Clinical Chemistry; Toxicology
Term: 05/12/2011 - 02/28/2015
Asst. Dean for Admissions
School of Medicine
2500 California Plaza
Omaha, NE 68178-0078
|Designated Federal Official|
Avena Russell, ABD, MS
Center for Devices and Radiological Health
Office of Device Evaluation
10903 New Hampshire Ave.
WO 66 Room #1535
Silver Spring, MD 20993
**David A. Armbruster, Ph.D.
Barbara M. Goldsmith, Ph.D., FACB
*Monica J. Harmon, R.N., M.P.H., M.S.N.
Karol E. Watson, M.D., Ph.D., FACC
William E. Winter, M.D.
* Consumer Representative